Business Health & beauty Paid
SDS Optic reports positive results of phase one clinical trial of inPROBE oncology diagnostic tool
21:01
SDS Optic SA announced positive results from the first phase of a clinical trial evaluating the efficacy and safety of its inPROBE® microprobe in assessing HER2 receptor expression in breast cancer patients.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
